Skip to main content

Nektar Therapeutics

NKTR
Exchange
Nasdaq
Industry
Pharmaceutical Preparations
SEC CIK
0000906709

In the last 90 days, Nektar Therapeutics insiders filed 0 open-market purchases and 3 sales; 239 institutions reported holding it in 13F filings for Q2 2026, worth $2.50B in total; no superinvestor holds it.

13F holders, Q1 2024

Institutional positions in Nektar Therapeutics as of Mar 31, 2024. Investment managers with $100 million or more in US stocks report their long positions on Form 13F within 45 days after each quarter ends. How 13F works

Institutional holders
123
−3 vs. Q4 2023
Shares held
113.0M
−6.23M (−5.2%) vs. Q4 2023
Total value
$105.5M
+$38.2M (+56.7%) vs. Q4 2023
New holders
16
20 more added
Sold out
19
49 more reduced

1 institution that held it in Q4 2023 haven't filed for Q1 2024 yet. Not filing isn't selling, so they aren't counted as sold out or in the changes above.

Compare with Q4 2023: new holders, sold out and not filed yet

Holders and value by quarter

Institutions reporting NKTR on Form 13F each quarter since Q1 2021, and the total value they reported. Values are as of each quarter end, so they also move with the share price.

Institutional holdersQ1 2024: 123 institutions
Q1 2021: 239 institutionsQ2 2021: 243 institutionsQ3 2021: 243 institutionsQ4 2021: 242 institutionsQ1 2022: 243 institutionsQ2 2022: 230 institutionsQ3 2022: 232 institutionsQ4 2022: 217 institutionsQ1 2023: 197 institutionsQ2 2023: 148 institutionsQ3 2023: 139 institutionsQ4 2023: 127 institutionsQ1 2024: 123 institutionsQ2 2024: 135 institutionsQ3 2024: 140 institutionsQ4 2024: 146 institutionsQ1 2025: 157 institutionsQ2 2025: 109 institutionsQ3 2025: 153 institutionsQ4 2025: 180 institutionsQ1 2026: 216 institutionsQ2 2026: 239 institutions
Value heldQ1 2024: $105.5M
Q1 2021: $3.40BQ2 2021: $2.89BQ3 2021: $3.01BQ4 2021: $2.35BQ1 2022: $947.6MQ2 2022: $693.8MQ3 2022: $561.4MQ4 2022: $381.7MQ1 2023: $121.2MQ2 2023: $79.3MQ3 2023: $85.3MQ4 2023: $67.3MQ1 2024: $105.5MQ2 2024: $168.0MQ3 2024: $182.9MQ4 2024: $123.6MQ1 2025: $84.2MQ2 2025: $197.7MQ3 2025: $820.2MQ4 2025: $732.2MQ1 2026: $1.94BQ2 2026: $2.50B
Institutions holding NKTR and their total value by quarter
QuarterHoldersValue
Q2 2026239$2.50B
Q1 2026216$1.94B
Q4 2025180$732.2M
Q3 2025153$820.2M
Q2 2025109$197.7M
Q1 2025157$84.2M
Q4 2024146$123.6M
Q3 2024140$182.9M
Q2 2024135$168.0M
Q1 2024123$105.5M
Q4 2023127$67.3M
Q3 2023139$85.3M
Q2 2023148$79.3M
Q1 2023197$121.2M
Q4 2022217$381.7M
Q3 2022232$561.4M
Q2 2022230$693.8M
Q1 2022243$947.6M
Q4 2021242$2.35B
Q3 2021243$3.01B
Q2 2021243$2.89B
Q1 2021239$3.40B

Institutions, Q1 2024

Shares, value and share of portfolio for each institution holding Nektar Therapeutics; share changes are against Q4 2023.

Institutions holding NKTR in Q1 2024
InstitutionSharesValue% of portfolioChange in sharesAction
Acuitas Investments, LLC1,280,604$1.20M0.60%+369,400+40.5%Added
Marshall Wace, LLP1,471,237$1.37M0.00%−915,004−38.3%Reduced
Assenagon Asset Management S.A.1,687,300$1.58M0.00%−778,967−31.6%Reduced
Jacobs Levy Equity Management, Inc1,911,186$1.79M0.01%−1,492,979−43.9%Reduced
Gsa Capital Partners LLP1,989,905$1.86M0.15%−3,265,885−62.1%Reduced
Geode Capital Management, LLC2,053,085$1.92M0.00%+13,471+0.7%Added
Lynx1 Capital Management LP2,068,842$1.93M0.50%+139,644+7.2%Added
Shay Capital LLC2,079,674$1.94M0.57%+2,079,674New
Two Sigma Investments, LP2,081,940$1.94M0.00%−95,041−4.4%Reduced
Two Sigma Advisers, LP2,240,342$2.09M0.00%−829,200−27.0%Reduced
Nantahala Capital Management, LLC2,475,954$2.31M0.23%+2,475,954New
D. E. Shaw & Co., Inc.2,548,990$2.38M0.00%−1,549,854−37.8%Reduced
Millennium Management LLC2,984,545$2.79M0.00%+1,388,396+87.0%Added
Citadel Advisors LLC3,193,714$2.98M0.00%−2,431,286−43.2%Reduced
Stonepine Capital Management, LLC3,480,409$3.25M2.58%+3,480,409New
TCG Crossover Management, LLC4,000,000$3.74M0.30%+4,000,000New
Renaissance Technologies LLC4,620,681$4.32M0.01%−704,794−13.2%Reduced
Monaco Asset Management SAM5,831,565$5.45M2.42%−141,822−2.4%Reduced
BlackRock Inc.5,878,293$5.49M0.00%−225,924−3.7%Reduced
Primecap Management Co6,966,647$6.51M0.00%−35,100−0.5%Reduced
Acadian Asset Management LLC7,569,063$7.07M0.02%−249,741−3.2%Reduced
Vanguard Group Inc12,049,138$11.3M0.00%+6,265+0.1%Added
Deep Track Capital, LP18,400,000$17.2M0.49%00.0%Unchanged
Tang Capital Management LLC0$00.00%−2,348,109−100.0%Sold out
XTX Topco Ltd0$00.00%−73,212−100.0%Sold out
HRT Financial LP0$00.00%−70,500−100.0%Sold out
Scientech Research LLC0$00.00%−30,224−100.0%Sold out
Two Sigma Securities, LLC0$00.00%−21,535−100.0%Sold out
Freestone Capital Holdings, LLC0$00.00%−20,000−100.0%Sold out
Raymond James Financial Services Advisors, Inc.0$00.00%−19,400−100.0%Sold out
Neuberger Berman Group LLC0$00.00%−14,622−100.0%Sold out
Cetera Advisors LLC0$00.00%−12,300−100.0%Sold out
Confluence Wealth Services, Inc.0$00.00%−11,685−100.0%Sold out
Choate Investment Advisors0$00.00%−11,580−100.0%Sold out
Tower Research Capital LLC (TRC)0$00.00%−10,284−100.0%Sold out
Simplex Trading, LLC0$00.00%−3,819−100.0%Sold out
Atlas Capital Advisors LLC0$00.00%−600−100.0%Sold out
PFS Partners, LLC0$00.00%−597−100.0%Sold out
The PNC Financial Services Group, Inc.0$00.00%−100−100.0%Sold out
Advisory Services Network, LLC0$00.00%−3−100.0%Sold out
McClarren Financial Advisors, Inc.0$00.00%−157−100.0%Sold out
Ronald Blue Trust, Inc.0$00.00%−362−100.0%Sold out
Strategic Investment Solutions, Inc.––––Not filed